SCHEMBL6234016

SCHEMBL6234016

CCOC(=O)CC1c2cc(Br)ccc2C(=O)N1CC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PIN1 Q13526 1/20 0.40
PIN4 Q9Y237 1/20 0.40
ALDH1A1 P00352 3/20 0.39
SMAD3 P84022 2/20 0.38
APAF1 O14727 1/20 0.38
IDO1 P14902 1/20 0.36
KDM1A O60341 1/20 0.36
ESR1 P03372 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
ATM Q13315 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27528482 0.91 ALDH1A1 (0.39) TDP2CYP1A2CYP2C9CYP2C19PIN1
SCHEMBL6231541 0.89 PIN1 (0.41) CYP1A2PIN1PIN4ALDH1A1IDO1
SCHEMBL6236384 0.87 ALDH1A1 (0.43) PIN1PIN4ALDH1A1MEN1KMT2A
SCHEMBL4473695 0.85 AKR1B1 (0.40) TDP2ALDH1A1MEN1KMT2ATSHR
SCHEMBL6233172 0.85 PIN1 (0.38) CYP1A2CYP2C9CYP2C19PIN1PIN4
SCHEMBL27528495 0.84 CYP11B1 (0.43) PIN1PIN4ALDH1A1IDO1
SCHEMBL27528478 0.84 IDO1 (0.52) CYP1A2PIN1PIN4ALDH1A1IDO1
SCHEMBL27552574 0.82 ALDH1A1 (0.44) CYP1A2CYP2C9CYP2C19PIN1PIN4
SCHEMBL18789154 0.80 BRD4 (0.43) TDP2CYP1A2CYP2C9CYP2C19MEN1
SCHEMBL13708557 0.80 PLAU (0.33) TDP2ALDH1A1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1290833-C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris SANOFI AVENTIS PHARMA GMBH (DE) 2006-12-20 CN disclosed
EP-1528923-A1 N-((3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL)ACETYL)GUANIDINE DERIVATIVES AS NHE1-INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS Aventis Pharma Deutschland GmbH (DE) 2005-05-11 EP disclosed
WO-2003101450-A1 N- ((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYL) GUANIDINE DERIVATIVES AS NHE-1 INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed